|
ZBTB9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.713960E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.818440E-01 |
| Normal-vs-Stage2 |
1.726620E-01 |
| Normal-vs-Stage3 |
4.504200E-01 |
| Normal-vs-Stage4 |
6.464000E-01 |
| Stage1-vs-Stage2 |
6.637000E-01 |
| Stage1-vs-Stage3 |
9.562200E-01 |
| Stage1-vs-Stage4 |
8.048600E-01 |
| Stage2-vs-Stage3 |
7.104000E-01 |
| Stage2-vs-Stage4 |
6.012800E-01 |
| Stage3-vs-Stage4 |
8.664800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.842770E-01 |
| Normal-vs-AfricanAmerican |
3.077200E-01 |
| Normal-vs-Asian |
9.437800E-01 |
| Caucasian-vs-AfricanAmerican |
9.751800E-01 |
| Caucasian-vs-Asian |
7.389200E-01 |
| AfricanAmerican-vs-Asian |
7.257800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.474400E-02 |
| Normal-vs-Female |
9.282600E-01 |
| Male-vs-Female |
6.253700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.085400E-01 |
| Normal-vs-Extreme_Weight |
1.559630E-02 |
| Normal-vs-Obese |
6.521800E-01 |
| Normal-vs-Extreme_Obese |
4.389800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.906600E-01 |
| Normal_Weight-vs-Obese |
4.221800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.053400E-01 |
| Extreme_Weight-vs-Obese |
5.976300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.316000E-01 |
| Obese-vs-Extreme_Obese |
7.216000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.305000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.132000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.456300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.903100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.266400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.051800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.748490E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.444000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.171700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.038000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.385000E-01 |
| Normal-VS-Type2 PRCC |
3.808500E-02 |
| Normal-VS-KIRP CIMP |
6.312500E-02 |
| Normal-VS-Unclassified PRCC |
7.732400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.986200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.692600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.970200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.663600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.797840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.798000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.565400E-04 |
| Normal-vs-N1 |
4.806000E-01 |
| Normal-vs-N2 |
2.181100E-03 |
| N0-vs-N1 |
6.704700E-03 |
| N0-vs-N2 |
1.032590E-01 |
| N1-vs-N2 |
3.549600E-02 |
|
|
